Geode Capital Management
ABOS icon

Geode Capital Management’s Acumen Pharmaceuticals ABOS Stock Holding History

Geode Capital Management’s Portfolio ABOS Stock Details ABOS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$3.05M Buy
1,141,858
+725,620
+174% +$1.79M ﹤0.01% 3090
2026
Q1 		$983K Buy
416,238
+6,032
+1% +$15.4K ﹤0.01% 3354
2025
Q4 		$866K Buy
410,206
+11,428
+3% +$22.7K ﹤0.01% 3422
2025
Q3 		$682K Buy
398,778
+2,152
+0.5% +$2.98K ﹤0.01% 3511
2025
Q2 		$460K Sell
396,626
-465,273
-54% -$500K ﹤0.01% 3582
2025
Q1 		$948K Sell
861,899
-8,656
-1% -$12.4K ﹤0.01% 3322
2024
Q4 		$1.5M Buy
870,555
+6,027
+0.7% +$14.5K ﹤0.01% 3229
2024
Q3 		$2.14M Buy
864,528
+52,395
+6% +$142K ﹤0.01% 3105
2024
Q2 		$1.97M Buy
812,133
+526,994
+185% +$1.68M ﹤0.01% 3133
2024
Q1 		$1.16M Buy
285,139
+20,536
+8% +$77.4K ﹤0.01% 3318
2023
Q4 		$1.02M Hold
264,603
– – ﹤0.01% 3347
2023
Q3 		$1.1M Buy
264,603
+97,783
+59% +$604K ﹤0.01% 3282
2023
Q2 		$802K Hold
166,820
– – ﹤0.01% 3439
2023
Q1 		$677K Hold
166,820
– – ﹤0.01% 3534
2022
Q4 		$900K Buy
166,820
+9,175
+6% +$61.6K ﹤0.01% 3391
2022
Q3 		$1.58M Buy
157,645
+48,796
+45% +$280K ﹤0.01% 3171
2022
Q2 		$511K Sell
108,849
-233,797
-68% -$878K ﹤0.01% 3744
2022
Q1 		$1.34M Buy
342,646
+170,767
+99% +$929K ﹤0.01% 3473
2021
Q4 		$1.16M Buy
171,879
+64,073
+59% +$704K ﹤0.01% 3643
2021
Q3 		$1.6M Buy
+107,806
New +$1.79M ﹤0.01% 3457

Other funds holding ABOS

RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
SCV
Sands Capital Ventures Arlington, Virginia $614M AUM 19.92% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Alyeska Investment Group
Alyeska Investment Group Chicago, Illinois $38.9B AUM 28.51% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
ACM
ADAR1 Capital Management Austin, Texas $2.19B AUM 374.99% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
KIA
Knollwood Investment Advisory Hunt Valley, Maryland $1.12B AUM 41.02% 1-Year Est. Return
IC
Ikarian Capital Dallas, Texas $928M AUM 596.14% 1-Year Est. Return
Hudson Bay Capital Management
Hudson Bay Capital Management Stamford, Connecticut $36.8B AUM 42.13% 1-Year Est. Return

Geode Capital Management's ABOS Position: Q2 2026 in Review

Geode Capital Management increased its Acumen Pharmaceuticals (ABOS) stake by 174% in Q2 2026, buying an estimated $1.79M and bringing the position to 1,141,858 shares worth $3.05M. The position accounts for ﹤0.01% of the portfolio, ranked #3090.

Geode Capital Management first reported a position in ABOS in Q3 2021 and has held it in 20 quarters since. 96 funds tracked by Wall St. Rank hold ABOS as of Q2 2026.

  • Geode Capital Management held 1,141,858 shares of Acumen Pharmaceuticals worth $3.05M as of Q2 2026.
  • Geode Capital Management bought 725,620 Acumen Pharmaceuticals shares in Q2 2026, an estimated $1.79M.
  • Acumen Pharmaceuticals made up ﹤0.01% of Geode Capital Management's portfolio in Q2 2026, its #3090 holding.
  • Geode Capital Management first reported a position in Acumen Pharmaceuticals in Q3 2021 and has held it in 20 quarters since.
  • 96 funds tracked by Wall St. Rank held Acumen Pharmaceuticals as of Q2 2026.

Based on Geode Capital Management's 13F filing for Q2 2026, filed 12 Aug 2026.